Research

Ovarian Cancer: Modern Treatment

In ovarian cancer, an illness that returns within six months of employment following platinum-based treatment is described as platinum-sensitive. A patient’s platinum-sensitivity status can vary…


Primary Care Doctors

Visits to principal care physicians have been befalling for decades in the U.S., and rising out-of-pocket costs are the main, although not the only, cause…



Lurbinectedin In SCLC

A new drug application (NDA) has been registered for expedited approval with the FDA for lurbinectedin in sufferers with small-cell lung cancer (SCLC) who have…



Treating Macular Disease: Issues To Remember

The investigators in Canada discovered that a treat-and-extend (T&E) regimen of administering ranibizumab to sufferers with neovascular age-related macular illness produced similar results to monthly…